Who invested in Linnaeus Therapeutics?
Linnaeus Therapeutics's investors include National Cancer Institute (NCI).

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$27Mraised across 2 rounds since 2026, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $4.5M sold, first sale Feb 2026
Source recordedSEC filing: $4.5M sold, first sale Feb 2026
Linnaeus Therapeutics's investors include National Cancer Institute (NCI).
Linnaeus Therapeutics has raised $27M across 2 rounds since 2026.
Linnaeus Therapeutics's most recent round was a Grant of $22M in Feb 2026.
Its most recent round, $22M in Feb 2026, is also its largest on record.
Linnaeus Therapeutics's first round on record, in Feb 2026, was backed by National Cancer Institute (NCI).
Linnaeus Therapeutics's latest named round is a Grant, in Feb 2026.
Linnaeus Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.